Since the pathogenesis of experimental and clinical CKD involves inflammatory and oxidative actions, and CAT manifests various therapeutic actions, including anti-inflammation and antioxidants [24,25], we thought that it would be compelling to evaluate the effectiveness of CAT in mitigating or preventing CKD in mice, which, to our knowledge, has not yet been reported. Here, CAT is linked to chronic kidney disease.